Advertisement

Thyroid Abnormalities in Heart Failure

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Cardiology Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Klein I.
        • Danzi S.
        Thyroid disease and the heart.
        Curr Probl Cardiol. 2016; 41: 65-92
        • Klein I.
        Endocrine disorders and cardiovascular disease.
        in: Bonow R.O. Mann D.L. Zipes D.P. Braunwald’s heart disease. 10th edition. WB Saunders and Company, St. Louis, MO2014: 1793-1808 ([Chapter 81])
        • Klein I.
        • Danzi S.
        Thyroid disease and the heart.
        Circulation. 2007; 116: 1725-1735
        • Ascheim D.D.
        • Hryniewicz K.
        Thyroid hormone metabolism in patients with congestive heart failure: the low triiodothyronine state.
        Thyroid. 2002; 12: 511-515
        • Hennessey J.V.
        • Klein I.
        • Woeber K.
        • et al.
        Aggressive case finding: a clinical strategy for the documentation of thyroid dysfunction.
        Ann Intern Med. 2015; 163: 311-312
        • Danzi S.
        • Ojamaa K.
        • Klein I.
        Triiodothyronine-mediated myosin heavy chain gene transcription in the heart.
        Am J Physiol Heart Circ Physiol. 2003; 284: H2255-H2262
        • Danzi S.
        • Klein I.
        Thyroid hormone and the cardiovascular system.
        Med Clin North Am. 2012; 96: 257-268
        • Dumitrescu A.M.
        • Liao X.H.
        • Weiss R.E.
        • et al.
        Tissue-specific thyroid hormone deprivation and excess in monocarboxylate transporter (Mct) 8-deficient mice.
        Endocrinology. 2009; 150: 4450-4458
        • Dillmann W.H.
        Cellular action of thyroid hormone on the heart.
        Thyroid. 2002; 12: 447-452
        • Davis P.J.
        • Davis F.B.
        Nongenomic actions of thyroid hormone on the heart.
        Thyroid. 2002; 12: 459-466
        • Danzi S.
        • Klein I.
        Changes in thyroid hormone metabolism and gene expression in the failing heart: therapeutic implications.
        in: Iervasi G. Pingitore A. Thyroid and heart failure, from pathophysiology to clinics. Springer-Verlag, Milan, Italy2009: 97-107 ([Chapter 10])
        • Kiss E.
        • Jakab G.
        • Kranias E.G.
        • et al.
        Thyroid-hormone-induced alterations in phospholamban protein expression: regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation.
        Circ Res. 1994; 75: 245-251
        • Shimizu T.
        • Koide S.
        • Noh J.Y.
        • et al.
        Hyperthyroidism and the management of atrial fibrillation.
        Thyroid. 2002; 12: 489-493
        • Park K.
        • Dai H.
        • Ojamaa K.
        • et al.
        Direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries.
        Anesth Analg. 1997; 85: 734-738
        • Taddei S.
        • Caraccio N.
        • Virdis A.
        • et al.
        Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.
        J Clin Endocrinol Metab. 2003; 88: 3731-3737
        • Kuzman J.A.
        • Gerdes A.M.
        • Kobayashi S.
        • et al.
        Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes.
        J Mol Cell Cardiol. 2005; 39: 841-844
        • Katzeff H.L.
        • Powell S.R.
        • Ojamaa K.
        Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3.
        Am J Physiol. 1997; 273: E951-E956
        • Klein I.
        • Ojamaa K.
        Thyroid hormone and the cardiovascular system.
        N Engl J Med. 2001; 344: 501-509
        • Iervasi G.
        • Pingitore A.
        • Landi P.
        • et al.
        Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease.
        Circulation. 2003; 107: 708-713
        • Cerillo A.G.
        • Storti S.
        • Kallushi E.
        • et al.
        The low triiodothyronine syndrome: a strong predictor of low cardiac output and death in patients undergoing coronary artery bypass grafting.
        Ann Thorac Surg. 2014; 97: 2089-2095
        • Hamilton A.M.
        Prevalence and clinical implications of abnormal thyroid hormone metabolism in advanced heart failure.
        Ann Thorac Surg. 1993; 56: S48-S53
        • Hamilton M.A.
        • Stevenson L.W.
        • Luu M.
        • et al.
        Altered hormone metabolism in advanced heart failure.
        J Am Coll Cardiol. 1990; 16: 91-95
        • Boelen A.
        • Maas M.A.
        • Lowik C.W.
        • et al.
        Induced illness in interleukin-6 (IL-6) knock-out mice: causal role of IL-6 in the development of the low 3,5,3’-triiodothyronine syndrome.
        Endocrinology. 1996; 137: 5250-5254
        • Danzi S.
        • Klein I.
        Thyroid disease and the cardiovascular system.
        Endocrinol Metab Clin North Am. 2014; 43: 517-528
        • Yu J.
        • Koenig R.J.
        Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice.
        Endocrinology. 2006; 147: 3580-3585
        • Lubrano V.
        • Pingitore A.
        • Carpi A.
        • et al.
        Relationship between triiodothyronine and proinflammatory cytokines in chronic heart failure.
        Biomed Pharmacother. 2010; 64: 165-169
        • De Vries E.M.
        • Fliers E.
        • Boelen A.
        The molecular basis of the non-thyroidal illness syndrome.
        J Endocrinol. 2015; 225: R67-R81
        • Zhang B.
        • Peng W.
        • Wang C.
        • et al.
        A low fT3 level as a prognostic marker in patients with acute myocardial infarctions.
        Intern Med. 2012; 51: 3009-3015
        • Selvaraj S.
        • Klein I.
        • Danzi S.
        • et al.
        Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction.
        Am J Cardiol. 2012; 110: 234-239
        • Klein I.
        • Danzi S.
        Thyroid hormone treatment to mend a broken heart.
        J Clin Endocrinol Metab. 2008; 93: 1172-1174
        • Pingitore A.
        • Galli E.
        • Barison A.
        • et al.
        Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study.
        J Clin Endocrinol Metab. 2008; 93: 1351-1358
        • Henderson K.
        • Danzi S.
        • Paul J.T.
        • et al.
        Physiological replacement of T3 improves left ventricular function in an animal model of myocardial infarction-induced congestive heart failure.
        Circ Heart Fail. 2009; 2: 243-252
        • Iervasi G.
        • Molinaro S.
        • Landi P.
        • et al.
        Association between increased mortality and mild thyroid dysfunction in cardiac patients.
        Arch Intern Med. 2007; 167: 1526-1532
        • Hejl J.L.
        • Grand M.K.
        • Siersma V.
        • et al.
        Brain natriuretic peptide in plasma as predictor of all-cause mortality in a large Danish primary health care population suspected of heart failure.
        Clin Chem. 2018; 64: 1723-1731
        • Chuang C.-P.
        • Jong Y.-S.
        • Wu C.-Y.
        • et al.
        Impact of triiodothyronine and N-terminal pro-B-type natriuretic peptide on the long-term survival of critically ill patients with acute heart failure.
        Am J Cardiol. 2014; 113: 845-850
        • Cappola A.R.
        • Ladenson P.W.
        Hypothyroidism and atherosclerosis.
        J Clin Endocrinol Metab. 2003; 88: 2438-2444
        • Scherer T.
        • Wolf P.
        • Winhofer Y.
        • et al.
        Levothyroxine replacement in hypothyroid humans reduces myocardial lipid load and improves cardiac function.
        J Clin Endocrinol Metab. 2014; 99: E2341-E2346
        • Ladenson P.W.
        • Kristensen J.D.
        • Ridgway E.C.
        • et al.
        Use of the thyroid hormone analogue eprotirome in statin-treated dyslipidemia.
        N Engl J Med. 2010; 362: 906-916
        • Lando H.M.
        • Burman K.D.
        Two cases of statin-induced myopathy caused by induced hypothyroidism.
        Endocr Pract. 2008; 14: 726-731
        • Rush J.
        • Danzi S.
        • Klein I.
        Role of thyroid disease in the development of statin-induced myopathy.
        Endocrinologist. 2006; 16: 279-285
        • Danzi S.
        • Klein I.
        Alterations in thyroid hormones which accompany cardiovascular disease.
        Clin Thyroidol. 2009; 21: 3-5